Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)

Market Cap	4.26B +22.7%
Revenue (ttm)	1.38B -16.4%
Net Income	14.25M
EPS	0.04
Shares Out	398.52M
PE Ratio	289.78
Forward PE	n/a
Dividend	0.20 (1.88%)
Ex-Dividend Date	n/a

Volume	3,023,467
Average Volume	9,211,918
Open	10.65
Previous Close	10.70
Day's Range	10.65 - 10.97
52-Week Range	8.74 - 14.55
Beta	0.56
RSI	56.68
Earnings Date	Apr 29, 2026

About SHE:301060

Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing; and professional technical support services. In addition, the company offers rental, business, and human resources services. Further, it operates Lan...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1993
• Employees: 1,365
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301060

Financial Performance

In 2025, SHE:301060's revenue was 1.45 billion, a decrease of -16.88% compared to the previous year's 1.74 billion. Losses were -30.75 million, -71.90% less than in 2024.